Publications

Latest publication 04/21/2021

Aminopeptidase A contributes to biochemical- anatomical and cognitive defects in

One of the main components of senile plaques in Alzheimer’s disease (AD)-affected brain is the Abeta peptide species harboring a pyroglutamate at...

Array
(
    [id_prestablog_news] => 1400
    [id_shop] => 1
    [date] => 2021-04-21 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 2983
    [id_lang] => 1
    [title] => Aminopeptidase A contributes to biochemical- anatomical and cognitive defects in
    [paragraph] => Aminopeptidase A contributes to biochemical- anatomical and cognitive defects in Alzheimer’s disease -AD- mouse model and is increased at early stage in sporadic AD brain
    [content] => 

Authors
A Valverde, J Dunys, T Lorivel et al


Lab
Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d’Azur, 660 route des Lucioles, Sophia-Antipolis, 06560, Valbonne, France

Journal
Acta Neuropathologica

Abstract
One of the main components of senile plaques in Alzheimer’s disease (AD)-affected brain is the Abeta peptide species harboring a pyroglutamate at position three pE3-Abeta. Several studies indicated that pE3-Abeta is toxic, prone to aggregation and serves as a seed of Abeta aggregation. The cyclisation of the glutamate residue is produced by glutaminyl cyclase, the pharmacological and genetic reductions of which significantly alleviate AD-related anatomical lesions and cognitive defects in mice models. The cyclisation of the glutamate in position 3 requires prior removal of the Abeta N-terminal aspartyl residue to allow subsequent biotransformation. The enzyme responsible for this rate-limiting catalytic step and its relevance as a putative trigger of AD pathology remained yet to be established. Here, we identify aminopeptidase A as the main exopeptidase involved in the N-terminal truncation of Abeta and document its key contribution to AD-related anatomical and behavioral defects. First, we show by mass spectrometry that human recombinant aminopeptidase A (APA) truncates synthetic Abeta1-40 to yield Abeta2-40. We demonstrate that the pharmacological blockade of APA with its selective inhibitor RB150 restores the density of mature spines and significantly reduced filopodia-like processes in hippocampal organotypic slices cultures virally transduced with the Swedish mutated Abeta-precursor protein (betaAPP). Pharmacological reduction of APA activity and lowering of its expression by shRNA affect pE3-42Abeta- and Abeta1-42-positive plaques and expressions in 3xTg-AD mice brains. Further, we show that both APA inhibitors and shRNA partly alleviate learning and memory deficits observed in 3xTg-AD mice. Importantly, we demonstrate that, concomitantly to the occurrence of pE3-42Abeta-positive plaques, APA activity is augmented at early Braak stages in sporadic AD brains. Overall, our data indicate that APA is a key enzyme involved in Abeta N-terminal truncation and suggest the potential benefit of targeting this proteolytic activity to interfere with AD pathology.

BIOSEB Instruments Used
Rotarod (BX-ROD),Aron Test or Four Plates Test (LE830)

Keywords/Topics
Alzheimer disease [meta_description] => [meta_keywords] => https://link.springer.com/article/10.1007/s00401-021-02308-0 [meta_title] => [link_rewrite] => aminopeptidase-a-contributes-to-biochemical--anatomical-and-cognitive-defects-in-alzheimers-disease--ad--mouse-model-and-is-increased-at-early-stage-in-sporadic-ad-brain [actif_langue] => 1 [read] => 294 [count_comments] => 0 [id] => 1400 [categories] => Array ( [46] => Array ( [id_prestablog_categorie] => 46 [title] => Alzheimer disease [link_rewrite] => alzheimer-disease ) [2] => Array ( [id_prestablog_categorie] => 2 [title] => Publications [link_rewrite] => publications ) ) [authors] => [paragraph_crop] => Aminopeptidase A contributes to biochemical- anatomical and cognitive defects in Alzheimer’s d [...] [link_for_unique] => 1 [products_liaison] => Array ( [1326] => Array ( [name] => Rotarod for rats and mice [description_short] =>

Rotarod provides an easy way to test the motor activity in rodents (mouse or rat) - an ideal solution for studying central nervous system damage, disease effects on motor activity, drugs administration, fatigue resistance, etc. Now even easier to use! The new touchscreen graphic user interface allows clear visualization of timing and speed for each lane. Change modes, adjust speed, and create protocols right from the main screen for greater flexibility with maximum functionality and usability

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/en/activity-motor-control-coordination/1326-rotarod.html ) [588] => Array ( [name] => Aron Test or Four Plates Test [description_short] =>

The Four Plates Test is an exclusivity from BIOSEB!
The Aron test allows a quick characterization of putative anxiolytics compounds in naïve animals. A must for studying anxiety, drug screening and phenotyping.

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/en/anxiety-depression-disorder/588-aron-test-or-four-plates-test.html ) ) ) 1
Read more

Filters

Applications

Dates

<< 1 ... 72 73 74 75 76 >>